You are viewing: China Nuclear Medicine Equipment Market analysis

The China Nuclear Medicine Equipment Market was valued at $431.8 Million in 2025 and projected to reach to $565.9 Million by 2030, representing a compound annual growth rate of 5.6%. China's nuclear medicine equipment market is positioned for sustained growth over the forecast period, supported by government healthcare reforms and increased healthcare spending.

China Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Nuclear Medicine Equipment Market Trends and Insights

  • This 5.6% compound annual growth rate reflects China's increasing investment in advanced diagnostic imaging technologies and healthcare infrastructure modernization.
  • China's aging population and rising prevalence of chronic diseases are driving demand for nuclear medicine diagnostic and therapeutic equipment across hospitals and diagnostic centers. The Chinese market benefits from government healthcare reforms and expanded insurance coverage that improve patient access to nuclear medicine procedures.
  • China's domestic manufacturers are strengthening their competitive position alongside international players, supported by favorable regulatory environments and manufacturing capabilities.
  • Between 2025 and 2030, China is expected to see accelerated adoption of PET-CT systems, SPECT equipment, and radiopharmaceuticals as healthcare providers prioritize precision medicine and early disease detection..

Key Market Statistics

  • CAGR (2025-2030) 5.6% CAGR
  • Market Size, 2025 ~USD 431.8 Million
  • Forecast, 2030 ~USD 565.9 Million
  • Country China

China Nuclear Medicine Equipment Market Overview

Market Valuation Growth :

China's nuclear medicine equipment market is valued at USD 431.8 million in 2025, with projections reaching USD 565.9 million by 2030, representing a robust 5.6% CAGR driven by healthcare modernization initiatives.

Aging Population Impact :

China's rapidly aging demographic is a key growth driver, with an increasing elderly population requiring advanced diagnostic imaging for chronic disease detection and management, fueling demand for nuclear medicine equipment.

Healthcare Infrastructure Investment :

Significant government investment in healthcare infrastructure modernization across China is accelerating the adoption of advanced diagnostic imaging technologies, including nuclear medicine equipment in hospitals and diagnostic centers.

Chronic Disease Prevalence :

Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions in China is driving the need for sophisticated nuclear medicine diagnostic and therapeutic equipment.

China Nuclear Medicine Equipment Market Dynamics

  • The country's focus on modernizing medical infrastructure and expanding diagnostic capabilities in both urban and emerging markets presents significant opportunities for equipment manufacturers and healthcare providers.
  • With a 5.6% CAGR outpacing the global average of 4.62%, China demonstrates stronger market dynamics driven by demographic shifts and disease burden increases. The market will benefit from technological advancements in imaging systems, growing awareness of early disease detection, and expanding reimbursement policies for nuclear medicine procedures.
  • Investment in training healthcare professionals and establishing nuclear medicine centers in tier-2 and tier-3 cities will further accelerate market penetration.
  • Strategic partnerships between international manufacturers and Chinese healthcare institutions are expected to enhance market accessibility and drive competitive innovation..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • China's nuclear medicine equipment market will grow from $431.8M (2025) to $565.9M (2030) at a 5.6% CAGR.
    • China's aging demographics and chronic disease burden are primary drivers of nuclear medicine equipment demand.
    • China's domestic manufacturers are gaining market share alongside international competitors through innovation and cost advantages.
    • Government healthcare reforms and insurance expansion in China are improving patient access to nuclear medicine diagnostics and therapeutics.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    China Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS56.760.163.767.571.575.780.184.85.9
    DIAGNOSTIC IMAGING CENTERS8590.496102.1108.4115.1122.2129.76.2
    HOSPITALS213224.8237249.8263.2277.3292.1307.55.3
    OTHER END USERS31.933.43536.738.440.24243.94.6
    TOTAL386.5408.7431.8456481.6508.3536.4565.95.6

    Target Audience

    • Medical Device Manufacturers : Equipment manufacturers need China-specific market data to develop localized product strategies, identify distribution channels, and understand competitive positioning in this 5.6% CAGR growth market.
    • Healthcare Facility Operators : Hospital administrators and diagnostic center operators require market insights to justify capital investments in nuclear medicine equipment, benchmark against peers, and plan facility expansion in China's modernizing healthcare landscape.
    • Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in China need validated market sizing, growth projections, and trend analysis to assess investment returns and identify acquisition targets in nuclear medicine.
    • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients on market entry, expansion, or strategic positioning require authoritative China market data to support client recommendations and competitive analysis.
    • Government & Policy Makers : Healthcare policy officials and government agencies need market intelligence on nuclear medicine equipment adoption to inform healthcare infrastructure planning, funding allocation, and regulatory framework development in China.

    Key Companies in the China Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 431.8M in 2025) with verified 5.6% CAGR forecasts through 2030, enabling accurate business planning and investment decisions specific to this high-growth market.
    • Competitive Landscape Intelligence : Understand China-specific competitive dynamics, key players, market share distribution, and strategic positioning to identify partnership opportunities and competitive advantages in this rapidly expanding healthcare sector.
    • Demographic & Disease Trend Analysis : Access detailed insights into China's aging population trends and chronic disease prevalence patterns that directly influence nuclear medicine equipment demand, enabling targeted product development and market entry strategies.
    • Regulatory & Reimbursement Framework : Gain comprehensive understanding of China's healthcare policies, regulatory requirements, reimbursement mechanisms, and government initiatives affecting nuclear medicine equipment adoption and market accessibility.
    • Regional Growth Opportunities : Identify high-potential geographic segments within China, including tier-2 and tier-3 city expansion opportunities, to optimize market penetration strategies and maximize revenue growth in underserved regions.

    Frequently asked questions

    What is the current size of China's nuclear medicine equipment market?

    China's nuclear medicine equipment market is valued at USD 431.8 million in 2025 and is projected to reach USD 565.9 million by 2030.

    What is the expected growth rate for China's nuclear medicine equipment market?

    China's nuclear medicine equipment market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.

    What factors are driving growth in China's nuclear medicine equipment market?

    Key drivers include China's aging population, rising prevalence of chronic diseases, government healthcare reforms, expanded insurance coverage, and increased adoption of precision medicine technologies.

    Who are the main competitors in China's nuclear medicine equipment market?

    China's nuclear medicine equipment market includes both international manufacturers and domestic Chinese companies that are strengthening their competitive positions through innovation and cost-effective solutions.

    What types of equipment are most in demand in China's nuclear medicine market?

    PET-CT systems, SPECT equipment, and radiopharmaceuticals are among the most in-demand nuclear medicine equipment categories in China as healthcare providers prioritize early disease detection and precision diagnostics.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status